We are live on ! Find out more
WIM

Woodford Investment Management Portfolio holdings

AUM $310M
1-Year Est. Return 17.41%
This Fund
S&P 500
This Quarter Est. Return
-13.56%
1 Year Est. Return
-17.41%
3 Year Est. Return
-27.14%
5 Year Est. Return
+68.29%
10 Year Est. Return
–
AUM
$1.16B
AUM Growth
-$99.4M
Cap. Flow
+$111M
Cap. Flow %
9.58%
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
5
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
AGIO icon
Agios Pharmaceuticals
AGIO
+$40.7M
2
AUTL
Autolus Therapeutics
AUTL
+$36.2M
3
NCNA
NuCana
NCNA
+$23M
4
TBPH icon
Theravance Biopharma
TBPH
+$16.8M
5
NITE
Nightstar Therapeutics plc American Depositary Shares
NITE
+$16.5M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$21.7M
2
ALKS icon
Alkermes
ALKS
+$737K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AUTL
1
Autolus Therapeutics
AUTL
$562M
$392M 33.87%
11,925,419
+1,099,500
+10% +$36.2M
TBPH icon
2
Theravance Biopharma
TBPH
$877M
$315M 27.26%
12,316,529
+621,650
+5% +$16.8M
PRTA icon
3
Prothena Corp
PRTA
$450M
$123M 10.62%
11,924,614
– –
AGIO icon
4
Agios Pharmaceuticals
AGIO
$1.93B
$91.2M 7.89%
1,977,459
+660,000
+50% +$40.7M
ALKS icon
5
Alkermes
ALKS
$8.25B
$77.9M 6.74%
2,639,676
-20,000
-0.8% -$737K
BIIB icon
6
Biogen
BIIB
$30.7B
$68.2M 5.9%
226,564
-68,000
-23% -$21.7M
EVFM
7
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$40.2M 3.48%
639,546
– –
NCNA
8
NuCana
NCNA
$6.12M
$27M 2.34%
373
+259
+227% +$23M
NITE
9
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
$22.1M 1.91%
1,921,315
+1,239,206
+182% +$16.5M

Similar funds

LCM
Lucha Capital Management San Francisco, California $327M AUM 2.87% 1-Year Est. Return
GWA
Guidant Wealth Advisors Palatine, Illinois $269M AUM 2.79% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
IPC
Invesco Private Capital New York $365M AUM 8.08% 1-Year Est. Return
AEPG
American Economic Planning Group Warren, New Jersey $367M AUM 2.51% 1-Year Est. Return
AR
Argyll Research Wilmington, Delaware $377M AUM 4.86% 1-Year Est. Return
KCM
Keywise Capital Management Grand Cayman, Cayman Islands $220M AUM 21.27% 1-Year Est. Return
COI
Capital One Investing Mclean, Virginia $430M AUM 3.49% 1-Year Est. Return

Woodford Investment Management's Q4 2018 Portfolio in Review

As of Q4 2018, Woodford Investment Management held 9 positions worth $1.16B, down 7.9% from $1.26B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Woodford Investment Management deployed $111M of net new capital in Q4 2018, adding to 5 existing holdings.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was Biogen, an estimated $21.7M trimmed.

  • Woodford Investment Management added most to Agios Pharmaceuticals in Q4 2018, an estimated $40.7M increase.
  • Woodford Investment Management's biggest Q4 2018 reduction was Biogen, cutting an estimated $21.7M.
  • Woodford Investment Management's ten largest holdings make up 100% of its $1.16B portfolio in Q4 2018.
  • Woodford Investment Management opened 0 new positions and closed 0 in Q4 2018.
  • Woodford Investment Management's portfolio value fell 7.9% quarter-over-quarter to $1.16B.

Based on Woodford Investment Management's 13F filing for Q4 2018, filed 14 Feb 2019.